There remains room for substantial improvement in today's reperfusion strategies. Combination therapy with fibrinolytic agents and GPIIb/IIIa antagonists appears to be a leading option available to enhance thrombolysis. However, before this strategy can be incorporated in routine practice protocols, it is necessary to define the optimal dosing and duration of therapy that will provide rapid reperfusion with minimal adverse effects.
|Journal||Journal of Emergency Medicine|
|Issue number||3 SUPPL.|
|State||Published - 2000|
ASJC Scopus subject areas
- Emergency Medicine